AudioEye (AEYE) Partners to Enhance Accessibility of Diabetic Eye Care with AI Solutions
- AEYE Health partners with Ford Medical to expand access to AI-driven diabetic eye exams in pharmacies nationwide.
- Their FDA-cleared AEYE-DS solution enables non-invasive, immediate retinal screenings without specialist intervention.
- The partnership aims to improve patient outcomes and create new revenue opportunities for non-acute care providers.
Enhancing Diabetic Eye Care Through Strategic Partnership
AEYE Health, recognized for its pioneering advancements in AI-powered retinal diagnostics, forms a strategic alliance with Ford Medical, a distributor focused on non-acute healthcare providers. This partnership seeks to broaden the accessibility of diabetic eye examinations by deploying AEYE Health's fully autonomous diabetic eye exam screening solutions across pharmacies and non-acute care centers nationwide. With diabetes rates surging alarmingly, diabetic retinopathy has emerged as the leading cause of blindness among working-age individuals. Alarmingly, a significant percentage of diabetic patients do not receive the annual screenings recommended to safeguard their vision. By introducing AI-driven technology into everyday healthcare settings, AEYE Health aspires to bridge this critical gap in care.
The centerpiece of this collaboration is AEYE-DS, the first FDA-cleared AI solution that operates with a portable camera, making retinal screening practical within pharmacy environments. This innovation enables pharmacies to offer in-house, non-invasive eye exams that yield immediate diagnostic results without requiring specialist intervention. As the healthcare landscape evolves, the integration of AEYE-DS into pharmacy services not only enhances patient care but also creates new revenue opportunities for providers. The initiative capitalizes on the existing CPT code for reimbursement, ensuring that healthcare providers can effectively deliver these essential screenings without financial barriers.
Zack Dvey-Aharon, CEO of AEYE Health, emphasizes the significance of this partnership in making diabetic eye exams more accessible to those in need. The collaboration also resonates with Ford Medical's Vice President of Sales, Scott Greenberg, who underscores the potential for delivering substantial clinical value through early disease detection. By leveraging autonomous AI technology, the partnership aims to facilitate timely interventions, ultimately preventing vision loss for millions of at-risk individuals while bolstering the capabilities of non-acute care providers.
In addition to enhancing access to diabetic eye care, this partnership underscores a growing trend within the healthcare industry to leverage technology for improved patient outcomes. As pharmacies expand their role in managing chronic conditions, the introduction of AI-powered screening solutions represents a significant shift towards more integrated healthcare delivery.
This collaboration not only addresses existing care gaps but also positions AEYE Health and Ford Medical at the forefront of a transformative movement in healthcare, where technology and accessibility converge to empower patients and healthcare providers alike.